Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.385 USD | +3.52% | -10.24% | +2.46% |
Jun. 01 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
May. 13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.46% | 2.27B | |
+11.71% | 3.43B | |
-19.19% | 2.03B | |
-19.74% | 1.63B | |
+33.44% | 1.16B | |
+16.42% | 714M | |
-8.30% | 703M | |
-22.86% | 500M | |
-4.97% | 279M | |
-16.50% | 161M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates